Securian Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.02M Hold
10,216
0.2% 71
2025
Q4
$5.92M Sell
10,216
-7,996
-44% -$4.52M 0.22% 59
2025
Q3
$8.83M Sell
18,212
-1,525
-8% -$710K 0.23% 69
2025
Q2
$8M Sell
19,737
-548
-3% -$229K 0.23% 79
2025
Q1
$10.1M Sell
20,285
-286
-1% -$155K 0.31% 56
2024
Q4
$10.7M Sell
20,571
-553
-3% -$304K 0.31% 52
2024
Q3
$13.1M Sell
21,124
-826
-4% -$489K 0.38% 43
2024
Q2
$12.1M Sell
21,950
-807
-4% -$462K 0.35% 47
2024
Q1
$13.2M Sell
22,757
-1,720
-7% -$965K 0.39% 46
2023
Q4
$13M Sell
24,477
-3,220
-12% -$1.56M 0.37% 48
2023
Q3
$14M Sell
27,697
-4,662
-14% -$2.48M 0.42% 41
2023
Q2
$16.9M Sell
32,359
-946
-3% -$510K 0.43% 40
2023
Q1
$19.2M Buy
33,305
+66
+0.2% +$37.2K 0.51% 35
2022
Q4
$18.3M Sell
33,239
-108
-0.3% -$57.2K 0.51% 35
2022
Q3
$16.9M Buy
33,347
+200
+0.6% +$112K 0.5% 36
2022
Q2
$18M Sell
33,147
-443
-1% -$244K 0.43% 50
2022
Q1
$19.8M Sell
33,590
-530
-2% -$304K 0.39% 47
2021
Q4
$22.8M Sell
34,120
-7
-0% -$4.37K 0.42% 43
2021
Q3
$19.5M Sell
34,127
-283
-0.8% -$155K 0.4% 51
2021
Q2
$17.4M Sell
34,410
-359
-1% -$169K 0.35% 60
2021
Q1
$15.9M Sell
34,769
-1,305
-4% -$623K 0.34% 66
2020
Q4
$16.8M Sell
36,074
-606
-2% -$284K 0.38% 59
2020
Q3
$16.2M Sell
36,680
-552
-1% -$228K 0.39% 56
2020
Q2
$13.5M Sell
37,232
-2,849
-7% -$955K 0.35% 64
2020
Q1
$11.4M Sell
40,081
-738
-2% -$233K 0.32% 72
2019
Q4
$13.3M Sell
40,819
-1,142
-3% -$346K 0.29% 83
2019
Q3
$12.2M Sell
41,961
-302
-0.7% -$86.5K 0.28% 85
2019
Q2
$12.4M Buy
42,263
+93
+0.2% +$25.6K 0.29% 83
2019
Q1
$11.5M Buy
42,170
+364
+0.9% +$90.6K 0.28% 94
2018
Q4
$9.36M Buy
41,806
+414
+1% +$97.1K 0.25% 98
2018
Q3
$10.1M Buy
41,392
+145
+0.4% +$33.4K 0.24% 101
2018
Q2
$8.54M Buy
41,247
+130
+0.3% +$27.6K 0.21% 109
2018
Q1
$8.49M Buy
41,117
+100
+0.2% +$21K 0.22% 108
2017
Q4
$7.79M Buy
41,017
+379
+0.9% +$72.6K 0.19% 126
2017
Q3
$7.69M Buy
40,638
+1,067
+3% +$193K 0.2% 122
2017
Q2
$6.9M Buy
39,571
+297
+0.8% +$49.9K 0.18% 130
2017
Q1
$6.03M Sell
39,274
-338
-0.9% -$51.7K 0.16% 140
2016
Q4
$5.59M Buy
39,612
+327
+0.8% +$48.2K 0.15% 158
2016
Q3
$6.25M Buy
39,285
+612
+2% +$94.3K 0.17% 134
2016
Q2
$5.71M Buy
38,673
+65
+0.2% +$9.59K 0.16% 138
2016
Q1
$5.47M Buy
38,608
+47
+0.1% +$6.3K 0.16% 145
2015
Q4
$5.47M Buy
38,561
+1,091
+3% +$146K 0.16% 140
2015
Q3
$4.58M Sell
37,470
-303
-0.8% -$39.5K 0.15% 143
2015
Q2
$4.9M Buy
37,773
+636
+2% +$82.9K 0.15% 147
2015
Q1
$4.99M Buy
37,137
+925
+3% +$119K 0.15% 156
2014
Q4
$4.54M Buy
36,212
+944
+3% +$115K 0.14% 161
2014
Q3
$4.29M Sell
35,268
-141
-0.4% -$17.1K 0.15% 158
2014
Q2
$4.18M Buy
35,409
+524
+2% +$61.7K 0.14% 158
2014
Q1
$4.2M Buy
34,885
+2,789
+9% +$332K 0.15% 146
2013
Q4
$3.57M Sell
32,096
-72
-0.2% -$7.16K 0.14% 177
2013
Q3
$2.96M Buy
32,168
+466
+1% +$42.1K 0.12% 190
2013
Q2
$2.68M Buy
+31,702
New +$2.64M 0.11% 196

Other funds holding TMO

Securian Asset Management's TMO Position: Q1 2026 in Review

Securian Asset Management held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 10,216 shares worth $5.02M. The position accounts for 0.2% of the portfolio, ranked #71.

Securian Asset Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $22.8M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Securian Asset Management held 10,216 shares of Thermo Fisher Scientific worth $5.02M as of Q1 2026.
  • Securian Asset Management left its Thermo Fisher Scientific share count unchanged in Q1 2026.
  • Thermo Fisher Scientific made up 0.2% of Securian Asset Management's portfolio in Q1 2026, its #71 holding.
  • Securian Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Securian Asset Management's Thermo Fisher Scientific position peaked at $22.8M in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Securian Asset Management's 13F filing for Q1 2026, filed 1 May 2026.